40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lung Niches for the Generation and Maintenance of Tissue-resident Memory T cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The extent to which tissue-specific viral infections generate memory T cells specifically adapted to and maintained within the target infection site is unknown. Here, we show that respiratory virus-specific memory T cells in mice and humans are generated and maintained in compartmentalized niches in lungs, distinct from populations in lymphoid tissue or circulation. Using a polyclonal mouse model of influenza infection combined with an in vivo antibody labeling approach and confocal imaging, we identify a spatially distinct niche in the lung where influenza-specific T cell responses are expanded and maintained long term as tissue resident memory (T RM) CD4 and CD8 T cells. Lung T RM are further distinguished from circulating memory subsets in lung and spleen based on CD69 expression and persistence independent of lymphoid stores. In humans, influenza-specific T cells are enriched within the lung T RM subset, while memory CD8 T cells specific for the systemic virus CMV are distributed in both lung and spleen, suggesting that the site of infection affects T RM generation. Our findings reveal a precise spatial organization to virus-specific T cell memory, determined by the site of the initial infection, with important implications for the development of targeted vaccination and strategies to boost immunity at appropriate tissue sites.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.

          Adaptive immunity depends on T-cell exit from the thymus and T and B cells travelling between secondary lymphoid organs to survey for antigens. After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown. An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors. However, the role of S1P receptors in normal immune cell trafficking is unclear. Here we show that in mice whose haematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus. Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph. Adoptive cell transfer experiments establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress. Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is associated with retention in lymphoid organs. We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacological S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration. These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Phenotypic analysis of antigen-specific T lymphocytes.

            Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lineage relationship and protective immunity of memory CD8 T cell subsets.

              Memory CD8 T cells can be divided into two subsets, central (T(CM)) and effector (T(EM)), but their lineage relationships and their ability to persist and confer protective immunity are not well understood. Our results show that T(CM) have a greater capacity than T(EM) to persist in vivo and are more efficient in mediating protective immunity because of their increased proliferative potential. We also demonstrate that, following antigen clearance, T(EM) convert to T(CM) and that the duration of this differentiation is programmed within the first week after immunization. We propose that T(CM) and T(EM) do not necessarily represent distinct subsets, but are part of a continuum in a linear naive --> effector --> T(EM) --> T(CM) differentiation pathway.
                Bookmark

                Author and article information

                Journal
                101299742
                35518
                Mucosal Immunol
                Mucosal Immunol
                Mucosal immunology
                1933-0219
                1935-3456
                18 October 2013
                25 September 2013
                May 2014
                01 November 2014
                : 7
                : 3
                : 501-510
                Affiliations
                [1 ]Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032., Columbia University Medical Center, New York, NY 10032
                [2 ]Department of Medicine, Columbia University Medical Center, New York, NY 10032., Columbia University Medical Center, New York, NY 10032
                [3 ]Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032., Columbia University Medical Center, New York, NY 10032
                [4 ]Department of Surgery, Columbia University Medical Center, New York, NY 10032., Columbia University Medical Center, New York, NY 10032
                [5 ]Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104
                Author notes
                To whom correspondence should be addressed: Donna L. Farber: Columbia Center for Translational Immunology, Columbia University Medical Center, 650 W 168th Street, New York, NY 10032; phone: 212-305-6030; FAX: 646-426-0019; df2396@ 123456cumc.columbia.edu
                Article
                NIHMS516311
                10.1038/mi.2013.67
                3965651
                24064670
                aa26b5df-a5f5-401e-b09f-46fbf2c3a459
                History
                Categories
                Article

                Immunology
                Immunology

                Comments

                Comment on this article